1-ethyl-2-benzimidazolinone has been researched along with Epilepsy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Forcelli, PA; Khandai, P; N'Gouemo, P | 1 |
Buño, W; Fernández de Sevilla, D; Galván, E; Garduño, J | 1 |
Brown, JT; Dale, TJ; Davies, CH; Lappin, SC; Trezise, DJ | 1 |
3 other study(ies) available for 1-ethyl-2-benzimidazolinone and Epilepsy
Article | Year |
---|---|
Activation of small conductance calcium-activated potassium channels suppresses seizure susceptibility in the genetically epilepsy-prone rats.
Topics: Action Potentials; Animals; Benzimidazoles; Epilepsy; Female; Male; Rats; Seizures; Small-Conductance Calcium-Activated Potassium Channels | 2020 |
1-Ethyl-2-benzimidazolinone (EBIO) suppresses epileptiform activity in in vitro hippocampus.
Topics: Action Potentials; Algorithms; Animals; Anticonvulsants; Apamin; Benzimidazoles; Calcium Channel Agonists; Electric Stimulation; Electrophysiology; Epilepsy; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyramidal Cells; Rats; Small-Conductance Calcium-Activated Potassium Channels; Synaptic Transmission | 2005 |
Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons.
Topics: Animals; Apamin; Benzimidazoles; Calcium Channel Agonists; Cell Line; CHO Cells; Cricetinae; Epilepsy; Evoked Potentials; Excitatory Postsynaptic Potentials; Extracellular Space; GABA Modulators; Hippocampus; Humans; Magnesium Deficiency; Male; Membrane Potentials; Models, Neurological; Neurons; Patch-Clamp Techniques; Potassium; Potassium Channels, Calcium-Activated; Rats; Recombinant Proteins | 2005 |